Boyd Matthew Ross 4
4 · enGene Holdings Inc. · Filed Jul 14, 2025
Insider Transaction Report
Form 4
Boyd Matthew Ross
Chief Regulatory Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-07-08+100,000→ 100,000 totalExercise: $3.83Exp: 2035-07-08→ Common Shares (100,000 underlying)
Footnotes (1)
- [F1]This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service.